---
title: "JD HEALTH deepens cooperation with Helion"
description: "JD HEALTH and Heliang deepen cooperation to build a new ecosystem of health services for comprehensive disease management and governance, innovating chronic disease management and full-cycle health ma"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272625422.md"
published_at: "2026-01-15T01:18:14.000Z"
---

# JD HEALTH deepens cooperation with Helion

> JD HEALTH and Heliang deepen cooperation to build a new ecosystem of health services for comprehensive disease management and governance, innovating chronic disease management and full-cycle health management models. The cooperation will expand to 15 fields including children's growth and development, respiratory system, and mental health. Heliang was spun off from GSK and listed in 2022, owning multiple consumer health brands. JD HEALTH is the largest pharmaceutical and health retail channel in China, and last year Heliang launched several new products on its platform

JD HEALTH (06618.HK) announced a deepened cooperation with multinational consumer health company Haleon. The two parties will comprehensively build a new ecosystem for health services focused on co-management and co-governance of diseases, promoting innovation from chronic disease management to full-cycle health management models. This year, the cooperation will expand to over 15 disease and health areas, including children's growth and development, respiratory system, mental health, skin and hair management, digestive health, and sexual health.

Haleon was spun off from GlaxoSmithKline (GSK.US) in 2022 and owns consumer health brands such as Panadol, Sensodyne, Voltaren, Flonase, and Centrum. JD HEALTH stated that as the largest, most comprehensive, and fastest-performing pharmaceutical and health retail channel in China, the company has the most extensive coverage of medical health services. Since last year, Haleon has successively launched multiple new products on the JD HEALTH platform, completing the iteration of 8 OTC products

### Related Stocks

- [06618.HK - JD HEALTH](https://longbridge.com/en/quote/06618.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 市场监管总局约谈阿里巴巴、抖音、百度、腾讯、京东、美团、淘宝闪购等平台企业 | 市场监管总局于 2 月 13 日约谈了阿里巴巴、抖音、百度、腾讯、京东、美团和淘宝闪购等平台企业，要求它们遵守相关法律法规，落实主体责任，规范促销行为，并杜绝 “内卷式” 竞争，以维护公平竞争市场环境，促进平台经济的创新与健康发展。 | [Link](https://longbridge.com/en/news/275975190.md) |
| 卖药之外，京东健康的新叙事 | 在互联网医疗经历了数年的 “线上问诊” 与 “医药电商” 的流量争夺战后，单纯的线上流量红利似乎已触及天花板… | [Link](https://longbridge.com/en/news/273957053.md) |
| 期权热点｜上周五 NBIS 大涨 9%，部分看涨期权飙升 378% | 美东时间 02 月 13 日，Nebius 期权总成交 179098 张，看涨期权占比 71%，看跌期权占比 28%。 | [Link](https://longbridge.com/en/news/276030151.md) |
| 早盘趋势｜京东物流回踩支撑，能否引发短线异动？ | 京东物流（2618.HK）近期股价延续弱势震荡，整体保持缩量调整格局，主要围绕关键支撑平台反复盘整。K 线整体阴线主导，5 日、10 日均线处于下行相互压制状态，短期均线呈现典型死叉结构。MACD 指标持续绿柱，技术空头情绪主导。 从基本面 | [Link](https://longbridge.com/en/news/274487771.md) |
| 港股异动：澜起科技涨 15.78%，花旗看好 AI 增长潜力，摩根大通增持助力股价攀升 | 澜起科技涨 15.78%；华虹半导体涨 1.57%，成交额达到 4.31 亿港币；中芯国际跌 0.36%，成交额达到 3.68 亿港币；兆易创新涨 14.27%，成交额达到 2.75 亿港币；豪威集团涨 0.79%，市值达到 1286 亿港 | [Link](https://longbridge.com/en/news/276028521.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.